About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Pharmacogenomics and Personalized Medicine
›
Top Articles
Pharmacogenomics and Personalized Medicine
Pharmacology
2.1
(top 8%)
Impact Factor
2.3
(top 8%)
extended IF
24
(top 15%)
H-Index
567
authors
484
papers
3.1K
citations
564
citing journals
2.1K
citing authors
Most Cited Articles of Pharmacogenomics and Personalized Medicine
Title
Year
Citations
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
2014
84
Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
2013
78
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy
2012
75
Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties
2014
71
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
2014
69
H3Africa: current perspectives
2018
58
Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway
2014
49
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
2016
48
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
2017
47
Emerging biomarkers in the diagnosis of prostate cancer
2018
47
Implementation and utilization of genetic testing in personalized medicine
2014
44
Glioblastoma extracellular vesicles: reservoirs of potential biomarkers
2014
43
The current and future state of companion diagnostics
2015
39
Pharmacogenomics of statins: understanding susceptibility to adverse effects
2016
38
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
2017
31
DNA methylation at the mu-1 opioid receptor gene () promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion
2017
29
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran
2017
29
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications
2019
29
Role of pharmacogenomics in the treatment of tuberculosis: a review
2012
29
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
2012
29
Olaparib in the management of ovarian cancer
2015
27
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
2018
25
Delivering pharmacogenetic testing in a primary care setting
2013
25
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
2011
25
Personalized medicine in breast cancer: pharmacogenomics approaches
2019
24
previous
2016
2017
2018
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.